查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1746526

日本败血症诊断市场报告（依诊断、产品、检测方式、技术、病原体、最终用户和地区）2025-2033

Japan Sepsis Diagnostics Market Report by Diagnosis, Product, Mode of Testing, Technology, Pathogen, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年，日本败血症诊断市场规模达2,410万美元。展望未来， IMARC Group预计到2033年，该市场规模将达到4,850万美元，2025-2033年期间的复合年增长率（CAGR）为7.4%。先进资料分析工具的日益普及，通常能够整合来自不同平台的多项检测结果，从而提供即时资料存取和精准的疾病诊断，是推动市场成长的主要动力。

败血症是人体在抵抗细菌、病毒或真菌感染时所产生的反应，进而引发败血症。在败血症状态下，免疫系统会释放各种化学物质进入血液，引发全身性过度发炎和血栓形成。败血症可导致多重器官衰竭、呼吸不规则、低血压、神经功能障碍、心跳加速等。检测败血症的诊断方法主要包括分子诊断、免疫测定、微流体技术、生物标记、流式细胞仪及其他类似技术。这些诊断技术广泛应用于各种医疗机构，包括医院、病理实验室、参考实验室和学术研究机构等。

日本败血症诊断市场趋势：

在日本市场，败血症诊断需求的激增可归因于几个关键因素。首先，可能导致败血症的医院内感染 (HAI) 显着增加，尤其是在老年人、婴儿和慢性病患者等弱势群体中。这一趋势是改善败血症诊断工具需求的驱动力。其次，由抗生素抗药性细菌（包括革兰氏阳性菌和革兰氏阴性菌）引起的传染病病例不断增加，这导致日本对败血症诊断的需求增加。这些抗生素抗药性菌株需要准确及时的诊断才能有效治疗。此外，日本不断扩张的医疗保健产业，加上先进资料分析工具的广泛应用，在催化败血症诊断市场的成长方面发挥着重要作用。这些工具能够整合来自不同平台的不同测试结果，提供对关键资料的即时存取和精确的疾病诊断。此外，持续的技术进步促进了新型免疫学和分子生物标记的开发，从而促进了败血症的早期检测。预计在预测期内，对包括用于识别和管理慢性感染的创新血液培养方法在内的广泛研发活动的投入，将有助于日本败血症诊断市场的扩张。

日本败血症诊断市场细分：

诊断见解：

  • 自动诊断
  • 常规诊断

产品洞察：

  • 仪器
  • 检测试剂盒和试剂
  • 血培养基
  • 软体

测试模式洞察：

  • 实验室检查
  • 即时检验

技术洞察：

  • 分子诊断
  • 免疫测定
  • 生物标誌物
  • 流式细胞仪
  • 微流体
  • 血液培养

病原体洞察：

  • 细菌性败血症
    • 革兰氏阳性细菌性败血症
    • 革兰氏阴性菌性败血症
  • 病毒性败血症
  • 霉菌性败血症
  • 其他的

最终用户洞察：

  • 诊断诊所
  • 医院
  • 研究实验室

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本败血症诊断市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对日本败血症诊断市场有何影响？
  • 根据诊断，日本败血症诊断市场是如何分類的？
  • 日本败血症诊断市场依产品分類的状况如何？
  • 根据检测方式，日本败血症诊断市场是如何分類的？
  • 日本败血症诊断市场依技术分類的分布如何？
  • 日本败血症诊断市场根据病原体是如何分類的？
  • 根据最终用户，日本败血症诊断市场是如何分類的？
  • 日本败血症诊断市场的价值链分为哪些阶段？
  • 日本败血症诊断的主要驱动因素和挑战是什么？
  • 日本败血症诊断市场的结构是怎么样的？主要参与者是谁？
  • 日本败血症诊断市场的竞争程度如何？

本报告回答的关键问题：

  • 日本败血症诊断市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对日本败血症诊断市场有何影响？
  • 根据诊断，日本败血症诊断市场是如何分類的？
  • 日本败血症诊断市场依产品分類的状况如何？
  • 根据检测方式，日本败血症诊断市场是如何分類的？
  • 日本败血症诊断市场依技术分類的分布如何？
  • 日本败血症诊断市场根据病原体是如何分類的？
  • 根据最终用户，日本败血症诊断市场是如何分類的？
  • 日本败血症诊断市场的价值链分为哪些阶段？
  • 日本败血症诊断的主要驱动因素和挑战是什么？
  • 日本败血症诊断市场的结构是怎么样的？主要参与者是谁？
  • 日本败血症诊断市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本败血症诊断市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本败血症诊断市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本败血症诊断市场-细分：依诊断

  • 自动诊断
    • 概述
  • 常规诊断
    • 概述

第七章：日本败血症诊断市场-细分：依产品

  • 仪器
    • 概述
  • 检测试剂盒和试剂
    • 概述
  • 血培养基
    • 概述
  • 软体
    • 概述

第 8 章：日本败血症诊断市场 - 细分：依检测方式

  • 实验室检查
    • 概述
  • 即时检验
    • 概述

第九章：日本败血症诊断市场-细分：依技术

  • 分子诊断
    • 概述
  • 免疫测定
    • 概述
  • 生物标誌物
    • 概述
  • 流式细胞仪
    • 概述
  • 微流体
    • 概述
  • 血液培养
    • 概述

第 10 章：日本败血症诊断市场 - 细分：按病原体

  • 细菌性败血症
    • 概述
    • 市场区隔
      • 革兰氏阳性细菌性败血症
      • 革兰氏阴性菌性败血症
  • 病毒性败血症
    • 概述
  • 霉菌性败血症
    • 概述
  • 其他的

第 11 章：日本败血症诊断市场 - 细分：按最终用户

  • 诊断诊所
    • 概述
  • 医院
    • 概述
  • 研究实验室
    • 概述

第 12 章：日本败血症诊断市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第十三章：关键参与者简介

  • Company A
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 14 章：日本败血症诊断市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 15 章：附录

简介目录
Product Code: SR112025A18716

Japan sepsis diagnostics market size reached USD 24.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 48.5 Million by 2033, exhibiting a growth rate (CAGR) of 7.4% during 2025-2033. The increasing adoption of advanced data analytics tools that generally enable the integration of multiple test results from different platforms to offer real-time data access and accurate disease diagnosis is primarily driving the market growth.

Sepsis is a medical condition that arises as a response of the body when it attempts to combat infections caused by the presence of bacteria, viruses, or fungi. In this state, the immune system releases various chemicals into the bloodstream, setting off excessive inflammation and the formation of blood clots throughout the body. Sepsis can lead to the failure of multiple organs, irregular breathing, low blood pressure, neurological dysfunction, an elevated heart rate, and more. The diagnostic methods for detecting sepsis primarily encompass molecular diagnosis, immunoassays, microfluidics, biomarkers, flow cytometry, and similar technologies. These diagnostic techniques see widespread use in various healthcare settings, including hospitals, pathology laboratories, reference laboratories, and academic research institutions, among others.

Japan Sepsis Diagnostics Market Trends:

In the Japanese market, the surge in demand for sepsis diagnostics can be attributed to several key factors. Firstly, there is a noticeable increase in hospital-acquired infections (HAIs) that can lead to sepsis, particularly among vulnerable demographic groups such as the elderly, infants, and patients with chronic ailments. This trend is a driving force behind the need for improved sepsis diagnostic tools. Secondly, the growing instances of infectious diseases caused by antibiotic-resistant bacteria, including both gram-positive bacteria and gram-negative bacilli, are contributing to the heightened demand for sepsis diagnostics in Japan. These antibiotic-resistant strains require accurate and timely diagnosis for effective treatment. Furthermore, Japan's expanding healthcare sector, coupled with the widespread adoption of advanced data analytics tools, is playing a significant role in catalyzing the growth of the sepsis diagnostics market. These tools enable the integration of diverse test results from various platforms, offering real-time access to critical data and precise disease diagnosis. Additionally, continuous technological advancements have led to the development of new immunological and molecular biomarkers, facilitating early sepsis detection. Investment in extensive research and development activities, including innovative blood culture methods for identifying and managing chronic infections, is expected to contribute to the expansion of the sepsis diagnostics market in Japan over the forecasted period.

Japan Sepsis Diagnostics Market Segmentation:

Diagnosis Insights:

  • Automated Diagnostics
  • Conventional Diagnostics

Product Insights:

  • Instruments
  • Assay Kits and Reagents
  • Blood Culture Media
  • Software

Mode of Testing Insights:

  • Laboratory Tests
  • Point-of-Care Tests

Technology Insights:

  • Molecular Diagnostics
  • Immunoassays
  • Biomarkers
  • Flow Cytometry
  • Microfluidics
  • Blood Culture

Pathogen Insights:

  • Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
    • Gram-Negative Bacterial Sepsis
  • Viral Sepsis
  • Fungal Sepsis
  • Others

End User Insights:

  • Diagnostic Clinics
  • Hospitals
  • Research Laboratories

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan sepsis diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan sepsis diagnostics market?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of diagnosis?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of product?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of mode of testing?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of technology?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of pathogen?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of end User?
  • What are the various stages in the value chain of the Japan sepsis diagnostics market?
  • What are the key driving factors and challenges in the Japan sepsis diagnostics?
  • What is the structure of the Japan sepsis diagnostics market and who are the key players?
  • What is the degree of competition in the Japan sepsis diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Sepsis Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Sepsis Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Sepsis Diagnostics Market - Breakup by Diagnosis

  • 6.1 Automated Diagnostics
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Conventional Diagnostics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)

7 Japan Sepsis Diagnostics Market - Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Assay Kits and Reagents
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Blood Culture Media
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Software
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)

8 Japan Sepsis Diagnostics Market - Breakup by Mode of Testing

  • 8.1 Laboratory Tests
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Point-of-Care Tests
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Sepsis Diagnostics Market - Breakup by Technology

  • 9.1 Molecular Diagnostics
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Immunoassays
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Biomarkers
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Flow Cytometry
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Microfluidics
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2019-2024)
    • 9.5.3 Market Forecast (2025-2033)
  • 9.6 Blood Culture
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2019-2024)
    • 9.6.3 Market Forecast (2025-2033)

10 Japan Sepsis Diagnostics Market - Breakup by Pathogen

  • 10.1 Bacterial Sepsis
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Segmentation
      • 10.1.3.1 Gram-Positive Bacterial Sepsis
      • 10.1.3.2 Gram-Negative Bacterial Sepsis
    • 10.1.4 Market Forecast (2025-2033)
  • 10.2 Viral Sepsis
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Fungal Sepsis
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2019-2024)
    • 10.3.3 Market Forecast (2025-2033)
  • 10.4 Others
    • 10.4.1 Historical and Current Market Trends (2019-2024)
    • 10.4.2 Market Forecast (2025-2033)

11 Japan Sepsis Diagnostics Market - Breakup by End User

  • 11.1 Diagnostic Clinics
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2019-2024)
    • 11.1.3 Market Forecast (2025-2033)
  • 11.2 Hospitals
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2019-2024)
    • 11.2.3 Market Forecast (2025-2033)
  • 11.3 Research Laboratories
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2019-2024)
    • 11.3.3 Market Forecast (2025-2033)

12 Japan Sepsis Diagnostics Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Services Offered
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Services Offered
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Services Offered
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Services Offered
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Services Offered
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan Sepsis Diagnostics Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix